Clinical Trials Browser

Breast Neoplasms, Carcinoma, Colonic Neoplasms, Esophageal Neoplasms, Head and Neck Neoplasms, Kidney Neoplasms, Lung Neoplasms, Melanoma, Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Sarcoma, Stomach Neoplasms, Thyroid Neoplasms, Uterine Neoplasms

NCT04631731 2023-06-01

ICEMELT

Phase 1/2 Unknown

200 enrolled

DermatologicGastrointestinalGenitourinaryGynecologicOther solid neoplasmThoracic

Diabetes Mellitus, Insulin-Dependent, 12, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Hepatocellular, Melanoma, Mesothelioma, Stomach Neoplasms, Endometrial Neoplasms

NCT03787602 2023-03-02

Navtemadlin (KRT-232) With or Without Anti-PD-1/Anti-PD-L1 for the Treatment of Patients With Merkel Cell Carcinoma

Phase 1/2 Unknown

115 enrolled

Dermatologic

Carcinoma, Merkel Cell

NCT03374839 2022-05-06

Nivo-TIL

Phase 1/2 Unknown

11 enrolled

Dermatologic

Melanoma

NCT02076646 2022-04-14

A Phase I/II Dose Escalation Study of the Tumor-targeting Human L19-IL2 Monoclonal Antibody-cytokine Fusion Protein in Combination With Dacarbazine for Patients With Metastatic Melanoma

Phase 1/2 Unknown

96 enrolled

Dermatologic

Melanoma, Neoplasm Metastasis

NCT03161756 2022-04-07

CHARLI

Phase 1/2 Unknown

72 enrolled

Dermatologic

Melanoma

NCT05164393 2022-01-27

COAKS

Phase 1/2 Unknown

60 enrolled

Dermatologic

Keratosis, Actinic

NCT03715985 2022-01-11

NeoPepVac

Phase 1/2 Unknown

12 enrolled

Dermatologic

Melanoma, Neoplasm Metastasis

NCT05117138 2021-11-11

Safety and Efficacy of Chimeric Antigen Receptor T Lymphocytes for Patients With Intermediate and Advanced Tumors

Phase 1/2 Unknown

39 enrolled

DermatologicHead & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Melanoma

NCT05047276 2021-09-17

PULSE-UM

Phase 1/2 Unknown

16 enrolled

Dermatologic

Uveal Melanoma, Neoplasm Metastasis

NCT04521075 2021-08-16

A Phase Ib Trial to Evaluate the Safety and Efficacy of FMT and Nivolumab in Subjects With Metastatic or Inoperable Melanoma, MSI-H, dMMR or NSCLC

Phase 1/2 Unknown

42 enrolled

DermatologicThoracic

Carcinoma, Non-Small-Cell Lung, Melanoma

NCT03754179 2021-04-28

COMBI-R2

Phase 1/2 Unknown

63 enrolled

Dermatologic

Melanoma

NCT02913417 2021-04-19

Yttrium90, Ipilimumab, & Nivolumab for Uveal Melanoma With Liver Metastases

Phase 1/2 Unknown

26 enrolled

Dermatologic

Uveal Melanoma

NCT04021420 2020-08-20

SONIMEL01

Phase 1/2 Unknown

21 enrolled

Dermatologic

Melanoma

NCT03638206 2019-12-11

Autologous CAR-T/TCR-T Cell Immunotherapy for Malignancies

Phase 1/2 Unknown

73 enrolled

CNSDermatologicGastrointestinalGenitourinaryGynecologicLymphoidOther hematologic neoplasmOther solid neoplasmPlasma cellSarcomaThoracic

Burkitt Lymphoma, Carcinoma, Renal Cell, Esophageal Neoplasms, Glioma, Carcinoma, Hepatocellular, Leukemia, Myeloid, Lung Neoplasms, Lymphoma, Melanoma, Mesothelioma, Multiple Myeloma, Ovarian Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms, Sarcoma, Synovial, Colorectal Neoplasms

NCT02367547 2019-03-28

Superficial Basal Cell Cancer's Photodynamic Therapy: Comparing Three Photosensitizers: HAL and BF-200 ALA Versus MAL

Phase 1/2 Unknown

117 enrolled

Dermatologic

Carcinoma, Basal Cell, Neoplasms, Basal Cell

NCT02654821 2018-11-02

TCR

Phase 1/2 Unknown

12 enrolled

Dermatologic

Uveal Melanoma, Melanoma

NCT02990416 2016-12-13

A-dmDT390-bisFv(UCHT1) Fusion Protein With Ionizing Radiation and Pembrolizumab for the Treatment of Stage IV Melanoma

Phase 1/2 Unknown

63 enrolled

Dermatologic

Melanoma

NCT02759536 2016-06-07

In-hospital Neutron Irradiator (IHNI)-Based Boron Neutron Capture Therapy (BNCT) in the Treatment of Malignant Melanoma

Phase 1/2 Unknown

30 enrolled

Dermatologic

Melanoma

NCT02202200 2016-04-18

OPTIMUM

Phase 1/2 Unknown

40 enrolled

Dermatologic

Melanoma

NCT01882946 2015-10-07

Safety and Efficacy Study of DCVax-Direct in Solid Tumors

Phase 1/2 Unknown

60 enrolled

DermatologicGastrointestinal

Liver Neoplasms, Melanoma, Pancreatic Neoplasms, Colorectal Neoplasms

NCT02154451 2014-06-03

Transient Infrared Imaging for Early Detection of Skin Cancer

Phase 1/2 Unknown

400 enrolled

Dermatologic

Skin Neoplasms

NCT00553683 2014-01-14

Cyclophosphamide, Radiation Therapy, and Poly ICLC in Treating Patients With Unresectable, Recurrent, Primary, or Metastatic Liver Cancer

Phase 1/2 Unknown

50 enrolled

BreastDermatologicGastrointestinalGynecologic

Carcinoma, Ovarian Epithelial, Breast Neoplasms, Colonic Neoplasms, Carcinoma, Hepatocellular, Liver Neoplasms, Melanoma, Neoplasm Metastasis, Ovarian Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms, Colorectal Neoplasms

NCT00002817 2014-01-10

Vaccine Therapy in Treating Patients With Metastatic Melanoma

Phase 1/2 Unknown

30 enrolled

Dermatologic

Melanoma

NCT00538005 2014-01-10

Sorafenib, Bevacizumab, and Oxaliplatin in Treating Patients With Metastatic Malignant Melanoma

Phase 1/2 Unknown

54 enrolled

Dermatologic

Melanoma

NCT00004025 2014-01-06

Vaccine Therapy With or Without Interleukin-2 in Treating Patients With Stage III or Stage IV Melanoma

Phase 1/2 Unknown

36 enrolled

Dermatologic

Melanoma

NCT00010309 2014-01-06

Vaccine Therapy in Treating Patients Who Have Stage II, Stage III, or Stage IV Melanoma

Phase 1/2 Unknown

Dermatologic

Melanoma

NCT00423397 2013-12-19

Gefitinib and PEG-Interferon Alfa-2a in Treating Patients With Unresectable or Metastatic Skin Cancer

Phase 1/2 Unknown

16 enrolled

Dermatologic

Skin Neoplasms

NCT00126685 2013-09-17

Vaccine Therapy in Treating Patients With Stage IV Melanoma

Phase 1/2 Unknown

30 enrolled

Dermatologic

Melanoma

NCT01082198 2013-08-26

Melanoma Vaccine in Treating Patients With Stage III Melanoma After Surgery to Remove Lymph Nodes

Phase 1/2 Unknown

22 enrolled

Dermatologic

Melanoma

NCT01331915 2012-10-10

THERAVAC

Phase 1/2 Unknown

23 enrolled

Dermatologic

Melanoma

NCT01584115 2012-04-25

Clinical Trial of a Therapeutic Vaccine With NY-ESO-1 in Combination With the Adjuvant Monophosphoryl Lipid A (MPLA)

Phase 1/2 Unknown

15 enrolled

DermatologicGynecologicThoracic

Lung Neoplasms, Melanoma, Neoplasms, Ovarian Neoplasms

NCT00811759 2010-10-07

Sorafenib and Temozolomide in Treating Patients With Stage III or Stage IV Melanoma

Phase 1/2 Unknown

58 enrolled

Dermatologic

Melanoma

NCT00779896 2008-10-24

Tazarotene 0.1% Cream For the Treatment of Cutaneous T-Cell Lymphoma: A Prospective Study

Phase 1/2 Unknown

15 enrolled

DermatologicLymphoid

Lymphoma, T-Cell, Cutaneous

NCT00108875 2006-07-28

Survivin Peptide Vaccination for Patients With Advanced Melanoma, Pancreatic, Colon and Cervical Cancer

Phase 1/2 Unknown

70 enrolled

DermatologicGastrointestinalGynecologic

Uterine Cervical Neoplasms, Colonic Neoplasms, Melanoma, Pancreatic Neoplasms

NCT00111046 2005-11-10

Pain Relief - Tramadol Versus Ibuprofen

Phase 1/2 Unknown

40 enrolled

Dermatologic

Uveal Melanoma, Eye Neoplasms, Melanoma

Clinical Trials

CELEBRATE

ACTME

PV-10 in Combination With Pembrolizumab for Treatment of Metastatic Melanoma

A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents

Imatinib Mesylate in Combination With Pembrolizumab in Patients With Melanoma

Phase I/II Study of Linperlisib Plus Chidamide for R/R Cutaneous T-cell Lymphoma: a Prospective, Single-center Study

A Clinical Trial of KVA12123 Treatment Alone and in Combination With Pembrolizumab In Advanced Solid Tumors (VISTA-101)

ICEMELT

Navtemadlin (KRT-232) With or Without Anti-PD-1/Anti-PD-L1 for the Treatment of Patients With Merkel Cell Carcinoma

Nivo-TIL

A Phase I/II Dose Escalation Study of the Tumor-targeting Human L19-IL2 Monoclonal Antibody-cytokine Fusion Protein in Combination With Dacarbazine for Patients With Metastatic Melanoma

CHARLI

COAKS

NeoPepVac

Safety and Efficacy of Chimeric Antigen Receptor T Lymphocytes for Patients With Intermediate and Advanced Tumors

PULSE-UM

A Phase Ib Trial to Evaluate the Safety and Efficacy of FMT and Nivolumab in Subjects With Metastatic or Inoperable Melanoma, MSI-H, dMMR or NSCLC

COMBI-R2

Yttrium90, Ipilimumab, & Nivolumab for Uveal Melanoma With Liver Metastases

SONIMEL01

Autologous CAR-T/TCR-T Cell Immunotherapy for Malignancies

Superficial Basal Cell Cancer's Photodynamic Therapy: Comparing Three Photosensitizers: HAL and BF-200 ALA Versus MAL

TCR

A-dmDT390-bisFv(UCHT1) Fusion Protein With Ionizing Radiation and Pembrolizumab for the Treatment of Stage IV Melanoma

In-hospital Neutron Irradiator (IHNI)-Based Boron Neutron Capture Therapy (BNCT) in the Treatment of Malignant Melanoma

OPTIMUM

Safety and Efficacy Study of DCVax-Direct in Solid Tumors

Transient Infrared Imaging for Early Detection of Skin Cancer

Cyclophosphamide, Radiation Therapy, and Poly ICLC in Treating Patients With Unresectable, Recurrent, Primary, or Metastatic Liver Cancer

Vaccine Therapy in Treating Patients With Metastatic Melanoma

Sorafenib, Bevacizumab, and Oxaliplatin in Treating Patients With Metastatic Malignant Melanoma

Vaccine Therapy With or Without Interleukin-2 in Treating Patients With Stage III or Stage IV Melanoma

Vaccine Therapy in Treating Patients Who Have Stage II, Stage III, or Stage IV Melanoma

Gefitinib and PEG-Interferon Alfa-2a in Treating Patients With Unresectable or Metastatic Skin Cancer

Vaccine Therapy in Treating Patients With Stage IV Melanoma

Melanoma Vaccine in Treating Patients With Stage III Melanoma After Surgery to Remove Lymph Nodes

THERAVAC

Clinical Trial of a Therapeutic Vaccine With NY-ESO-1 in Combination With the Adjuvant Monophosphoryl Lipid A (MPLA)

Sorafenib and Temozolomide in Treating Patients With Stage III or Stage IV Melanoma

Tazarotene 0.1% Cream For the Treatment of Cutaneous T-Cell Lymphoma: A Prospective Study

Survivin Peptide Vaccination for Patients With Advanced Melanoma, Pancreatic, Colon and Cervical Cancer

Pain Relief - Tramadol Versus Ibuprofen